These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 25416345)

  • 1. The role and treatment of inflammation in dry eye disease.
    Yagci A; Gurdal C
    Int Ophthalmol; 2014 Dec; 34(6):1291-301. PubMed ID: 25416345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye.
    Gaffney EA; Tiffany JM; Yokoi N; Bron AJ
    Prog Retin Eye Res; 2010 Jan; 29(1):59-78. PubMed ID: 19944776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry eyes: etiology and management.
    Latkany R
    Curr Opin Ophthalmol; 2008 Jul; 19(4):287-91. PubMed ID: 18545008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye.
    Julio G; Lluch S; Pujol P; Merindano MD
    Ophthalmic Physiol Opt; 2012 Jul; 32(4):317-23. PubMed ID: 22620852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Replacement Improves Tear Osmolarity in Patients with Vitamin D Deficiency.
    Kizilgul M; Kan S; Ozcelik O; Beysel S; Apaydin M; Ucan B; Cakal E
    Semin Ophthalmol; 2018; 33(5):589-594. PubMed ID: 28876961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tears osmolarity in dry eye].
    Aguilar AJ
    Arq Bras Oftalmol; 2008; 71(6 Suppl):69-71. PubMed ID: 19274415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
    Sullivan BD; Crews LA; Sönmez B; de la Paz MF; Comert E; Charoenrook V; de Araujo AL; Pepose JS; Berg MS; Kosheleff VP; Lemp MA
    Cornea; 2012 Sep; 31(9):1000-8. PubMed ID: 22475641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmolality and tear film dynamics.
    Stahl U; Willcox M; Stapleton F
    Clin Exp Optom; 2012 Jan; 95(1):3-11. PubMed ID: 22022802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular mechanisms of dry eye: from pathogenesis to treatment.
    Mantelli F; Massaro-Giordano M; Macchi I; Lambiase A; Bonini S
    J Cell Physiol; 2013 Dec; 228(12):2253-6. PubMed ID: 23696296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmokinetics: A new dynamic concept in dry eye disease.
    van Setten GB
    J Fr Ophtalmol; 2019 Mar; 42(3):221-225. PubMed ID: 30851972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic inhibitors for the treatment of dry eye syndrome.
    Rodríguez-Pomar C; Pintor J; Colligris B; Carracedo G
    Expert Opin Pharmacother; 2017 Dec; 18(17):1855-1865. PubMed ID: 29115899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRY EYE DISEASE. A REVIEW.
    Zemanová M
    Cesk Slov Oftalmol; 2021; 77(3):107–119. PubMed ID: 34107689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tear osmolarity and dry eye].
    Pan SY; Xiao XH; Wang YZ; Liu XN; Zhu XP
    Zhonghua Yan Ke Za Zhi; 2011 May; 47(5):475-7. PubMed ID: 21756751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry eye disease in strabismus patients: Does eye deviation harm ocular surface?
    Giannaccare G; Versura P; Sebastiani S; Fariselli C; Pellegrini M; Campos E
    Med Hypotheses; 2018 Feb; 111():15-18. PubMed ID: 29406988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical guidelines for management of dry eye associated with Sjögren disease.
    Foulks GN; Forstot SL; Donshik PC; Forstot JZ; Goldstein MH; Lemp MA; Nelson JD; Nichols KK; Pflugfelder SC; Tanzer JM; Asbell P; Hammitt K; Jacobs DS
    Ocul Surf; 2015 Apr; 13(2):118-32. PubMed ID: 25881996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the tear film and ocular surface from dry eye syndrome.
    Johnson ME; Murphy PJ
    Prog Retin Eye Res; 2004 Jul; 23(4):449-74. PubMed ID: 15219877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tear physiology in ocular surface temperature.
    Craig JP; Singh I; Tomlinson A; Morgan PB; Efron N
    Eye (Lond); 2000 Aug; 14 ( Pt 4)():635-41. PubMed ID: 11040913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.